Author:
Zarbo Allison,Axelson Anna
Publisher
Springer International Publishing
Reference160 articles.
1. National Institutes of Health NCI. Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0 Nov, 2017. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf .
2. Cohen PR. Acral erythema: a clinical review. Cutis. 1993;51(3):175–9.
3. Burgdorf WH, Gilmore WA, Ganick RG. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. Ann Intern Med. 1982;97(1):61–2.
4. Hood AF, Haynes HA. Dermatologic complications. In: Holland JF, editor. Cancer medicine. 4th ed. Baltimore: Williams & Wilkins; 1997.
5. Miller KK, Gorcey L, McLellan BN. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol. 2014;71(4):787–94.